1. Home
  2. SOUNW vs ITRM Comparison

SOUNW vs ITRM Comparison

Compare SOUNW & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SoundHound AI Inc. Warrant

SOUNW

SoundHound AI Inc. Warrant

HOLD

Current Price

$4.00

Market Cap

0.0

Sector

Technology

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.30

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOUNW
ITRM
Founded
2005
2015
Country
United States
Ireland
Employees
842
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
24.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SOUNW
ITRM
Price
$4.00
$0.30
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
104.1K
704.9K
Earning Date
02-27-2025
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$67,297,000.00
$390,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$193.01
P/E Ratio
N/A
N/A
Revenue Growth
76.05
N/A
52 Week Low
$4.84
$0.30
52 Week High
$6.16
$2.10

Technical Indicators

Market Signals
Indicator
SOUNW
ITRM
Relative Strength Index (RSI) 30.72 25.10
Support Level $3.95 $0.44
Resistance Level $4.80 $0.37
Average True Range (ATR) 0.40 0.03
MACD -0.02 -0.01
Stochastic Oscillator 11.85 1.74

Price Performance

Historical Comparison
SOUNW
ITRM

About SOUNW SoundHound AI Inc. Warrant

SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: